Connect with us

Bloomberg Technology

Vir CEO: Omicron Is Probably Not the Last Variant

Vir Biotechnology President and CEO George Scangos joins Emily Chang following the news that its Covid-19 antibody treatment, co-developed with Glaxo, looks to be effective against the new omicron variant in early testing.

Published

on

Vir Biotechnology President and CEO George Scangos joins Emily Chang following the news that its Covid-19 antibody treatment, co-developed with Glaxo, looks to be effective against the new omicron variant in early testing.

Continue Reading
Advertisement
5 Comments

5 Comments

  1. Conor Roush

    December 3, 2021 at 12:44 am

    How convenient, a new shot coming up. Lmao.

  2. SCOTT WATSON

    December 3, 2021 at 1:42 am

    OMICRON anagrams into MORONIC, MODERNA anagrams into DREAM ON, …… and DELTA OMICRON anagrams into MEDIA CONTROL

  3. Patrick Dempsey

    December 3, 2021 at 6:33 am

    I found how to get an exact number of COVID variants to expect: Count the number of influenza variants since it came up, add zero, divide by one. That’s how many COVID variants there will be.

  4. Boy Bata

    December 3, 2021 at 3:29 pm

    Communist Chang’s favorite subject

  5. Treatment for pneumonia and inflammation.

    December 4, 2021 at 12:27 am

    Apply the following diet plan strictly for some days during covid 19 infection and you have no fear of any type of pneumonia and inflammation.
    Non – inflammatory food list
    1. All the meaty products (everything, like eggs,  pork, beef, mutton, chicken, fish etc. ). 
    2. Wheat ( and all the products that are made from pure wheat, not biscuits or cookies because they contain vegetables oil). 
    3. Gram, cheakpea( chana or kabuli chana). Masoor dal.
    5. Green leaves like spinach, lettuce, etc.  ( green leaves mustn’t be sour or bitter ). 
    6. All the Derry products (they must be made of pure animal milk like butter clarified,  curd, cheese, fresh milk ). 
    7. Pure Mustard oil, turmeric powder, red chili powder , white sugar, sea salt, coriander powder and leaves, butter clarified. 
    8. Lemon ( lemon is a non – inflammatory thing  but it acts differently with different  foods, with the suggested foods it would never be a cause for inflammation). 
    If someone  get affected with covid 19, he must avoid lemon for some days because he already would have eaten something that lemon acts as inflammatory thing. But if the patient eating strictly the suggested diet for more than 18 days then he can add lemon  in your regular diet it will never be inflammatory then. The patient has to apply this diet plan very very strictly because consumption of a single fruit, vegetable, or non suggested grain, lentil or vegetable oil can affect the whole result.
    Note- feed your infants with mother milk or pure animal milk,( formula  milk acts like a poison during the covid 19 infection because it contains vegetables oil)………

Leave a Reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

Anthropic Files for IPO in Global Race to Raise Cash for AI

Anthropic filed for its long-awaited IPO, a landmark moment in an industry that is growing ever-hungrier for cash to power ahead. Ed Ludlow reports. ——– Like this video? Subscribe to Bloomberg Tech on YouTube:   Watch the latest full episodes of “Bloomberg Tech” with Ed Ludlow here:   Get the latest in tech from Silicon…

Published

on

Anthropic filed for its long-awaited IPO, a landmark moment in an industry that is growing ever-hungrier for cash to power ahead. Ed Ludlow reports.
——–
Like this video? Subscribe to Bloomberg Tech on YouTube:

 
Watch the latest full episodes of “Bloomberg Tech” with Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
 
Listen to the daily Bloomberg Tech podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

Anthropic Drops Its S-1, Giving Market Glimpse Into Finances

Bloomberg’s Ed Ludlow takes a look at Anthropic’s regulatory filing as the company prepares to go public under the ticker ANT. The S-1 revealed Anthropic’s revenue and spending, along with its plan for an unusual corporate structure. Plus, venture investors are in line for a big payday when Anthropic goes public. Matt Murphy from Menlo…

Published

on

Bloomberg’s Ed Ludlow takes a look at Anthropic’s regulatory filing as the company prepares to go public under the ticker ANT. The S-1 revealed Anthropic’s revenue and spending, along with its plan for an unusual corporate structure. Plus, venture investors are in line for a big payday when Anthropic goes public. Matt Murphy from Menlo Ventures and Byron Deeter from Bessemer Venture Partners discuss what they think happens next for the AI market.

00:00:00 – Bloomberg Tech Begins
00:00:45 – Shirin Ghaffary & Sridhar Natarajan on Anthropic IPO filing
00:06:03 – Gil Luria, DA Davidson on Anthropic’s cost of compute
00:15:06 – Lori Keith, Parnassus Investments on Anthropic Investments
00:21:01 – Sarah Frier on Meta raising money for AI spending
00:23:31 – Brody Ford on Microsoft offering buyouts to 60,000 workers
00:24:47 – Natasha Mascarenhas on Anthropic funding details
00:27:47 – Rohit Kulkarni, Burnham Park on Anthropic IPO filing
00:34:20 – Byron Deeter, Bessemer Venture Partners on Anthropic
00:41:58 – Rachel Metz, Bloomberg News
00:44:13 – Matt Murphy, Menlo Ventures on Anthropic IPO
——–
“Bloomberg Technology” is our daily news program focused exclusively on technology, innovation and the future of business hosted by Ed Ludlow from San Francisco and Caroline Hyde in New York.

Like this video? Subscribe and turn on the notifications for Bloomberg Technology on YouTube:

Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

Get the latest in tech from Silicon Valley and around the world here:

Follow Ed Ludlow on Twitter here:
Follow Caroline Hyde on Twitter here:

Connect with us on…
Twitter:
Facebook:
Instagram:

Continue Reading

Bloomberg Technology

Anthropic IPO Is the “One We’ve Been Waiting For”: Bessemer’s Deeter

Anthropic’s IPO will finally give public market investors a chance to get into the software side of AI, says Byron Deeter, partner at Bessemer Venture Partners. Bessemer first invested in Anthropic during its Series D, and Deeter explains the impact Anthropic going public will have on limited partners. He joins Ed Ludlow on “Bloomberg Tech”.…

Published

on

Anthropic’s IPO will finally give public market investors a chance to get into the software side of AI, says Byron Deeter, partner at Bessemer Venture Partners. Bessemer first invested in Anthropic during its Series D, and Deeter explains the impact Anthropic going public will have on limited partners. He joins Ed Ludlow on “Bloomberg Tech”.
——–
Like this video? Subscribe to Bloomberg Tech on YouTube:

 
Watch the latest full episodes of “Bloomberg Tech” with Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
 
Listen to the daily Bloomberg Tech podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Trending